The global peptide synthesis market is a vital segment of the healthcare industry. Peptides are short chains of amino acids that can be used in drug development and other medical applications. Custom peptide synthesis allows researchers to procure short run peptides for clinical trials and research projects in a cost-effective manner. Peptide synthesis is carried out through either solid-phase or liquid-phase methods and has applications across various domains including pharmaceutical, biotechnology, diagnostic and chemical industries. The availability of custom peptide synthesis services has accelerated research activities in drug discovery, immunology and protein-protein interaction studies.

The Global peptide synthesis market is estimated to be valued at US$ 490.58 Mn in 2024 and is expected to exhibit a CAGR of 7.4% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the peptide synthesis market include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth.

The Peptide Synthesis Market Trends  for customized peptides from biotech and pharma companies for pre-clinical and clinical research. Furthermore, the development of novel solid phase peptide synthesis techniques such as SPOT synthesis will further augment the capabilities of peptide synthesis platforms.

Technological advancements in the field of automated peptide synthesis such as microwave assisted peptide synthesis is also expected to support market growth over the forecast period. These technological upgrades help minimize reaction times and improve reproducibility of results.

Get More Insights On, Peptide Synthesis Market